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The terms ‘exercise-induced asthma’ (EIA) and ‘exercise-induced bronchoconstriction’ (EIB) are often used
interchangeably to describe symptoms of asthma such as cough, wheeze, or dyspnoea provoked by vigorous
physical activity. In this review, we refer to EIB as the bronchoconstrictive response and to EIA when bron-
choconstriction is associated with asthma symptoms. EIB is a common occurrence for most of the asthmatic
patients, but it also affects more than 10% of otherwise healthy individuals as shown by epidemiological studies.
EIA and EIB have a high prevalence also in elite athletes, especially within endurance type of sports, and an
athlete’s asthma phenotype has been described. However, the occurrence in elite athletes shows that EIA/EIB,
if correctly managed, may not impair physical activity and top sports performance. The pathogenic mechanisms
of EIA/EIB classically involve both osmolar and vascular changes in the airways in addition to cooling of
the airways with parasympathetic stimulation. Airways inflammation plays a fundamental role in EIA/EIB.
Diagnosis and pharmacological management must be carefully performed, with particular consideration
of current anti-doping regulations, when caring for athletes. Based on the demonstration that the inhaled
asthma drugs do not improve performance in healthy athletes, the doping regulations are presently much less
strict than previously. Some sports are at a higher asthma risk than others, probably due to a high environmental
exposure while performing the sport, with swimming and chlorine exposure during swimming as one example.
It is considered very important for the asthmatic child and adolescent to master EIA/EIB to be able to
participate in physical activity on an equal level with their peers, and a precise early diagnosis with optimal
treatment follow-up is vital in this aspect. In addition, surprising recent preliminary evidences offer new
perspectives for moderate exercise as a potential therapeutic tool for asthmatics.
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E
xercise-induced respiratory symptoms were first
described by Araeteus the Cappadocian in the
1st century A.D. (‘if from running, gymnastics, or
any other work, breathing becomes difficult, it is called
‘‘Asthma’’’). In the ‘modern’ era, Jones et al. (1) firstly des-
cribed in 1962 the effects of exercise on ventilatory function
in children, together with systematic exercise tests.
The terms ‘exercise-induced asthma’ (EIA) and ‘exercise-
induced bronchoconstriction’ (EIB) are often used inter-
changeably. A consensus between the American Academy
of Allergy, Asthma and Immunology (AAAAI), the
American College of Allergy, Asthma and Immunology
(ACAAI), and the Joint Council of Allergy, Asthma and
Immunology (JCAAI) used the term ‘EIB with asthma’
for exercise-induced bronchoconstriction (EIB) with clini-
cal symptoms of asthma and ‘EIB without asthma’ for an
acute airflow obstruction without asthma symptoms (2).
A joint Task force of European Academy of Allergy and
Clinical Immunology and European Respiratory Society
defined EIA as symptoms of asthma occurring after
heavy exercise, whereas EIB denoted the reduction
in lung function occurring after exercise, as seen in a
standardized exercise test (3). In this review, we will refer
to EIB as the bronchoconstrictive response while EIA also
includes EIBasthma symptoms. The two conditions
will be discussed separately when the populations are
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specifically identified; otherwise, they are collectively
referred to as EIB/EIA.
Aim of this review is to provide the reader with the
current knowledge on this topic, focusing in particular
on the athlete’s asthma phenotype, together with a para-
graph on new perspectives for exercise as a therapeutic
tool for asthmatics.
It has been claimed that up to 7580% of asthmatic
subjects without anti-inflammatory treatment may experi-
ence an asthma attack provoked by exercise (4), but also
individuals without a diagnosis of asthma may experience
a significant reduction in lung function after heavy exercise,
sometimes representing a risk factor for the development
of asthma (5). Whereas the physiologic response to exercise
usually result in slight bronchodilation, in population-based
studies individuals without an asthma diagnosis may also
suffer from EIB (6).
A minimum of 58 min continuous high-intensity
effort is required to develop an exercise-induced bronch-
oconstrictive response. EIB is usually observed 210 min
after heavy exercise, and not during maximum exercise
intensity. However, in a study from Van Leeuwen et al.,
EIB occurred in children during sub-maximal exercise,
not after (7).
Children and adolescents are more frequently affec-
ted than adults (8) and in the Oslo birth cohort study
‘Environment Childhood Study’ 36.7% of 10-year-old
children with a diagnosis of asthma showed EIB, with a
positive exercise test, while 8.6% had a positive EIB test
in the entire population-based birth cohort (6).
Elite athletes also have an increased risk for EIA/EIB,
especially those that participate in endurance sports such
as swimming, running, and cycling and in winter sports (9).
Despite this increased prevalence, it is reassuring that
many asthmatic elite athletes with optimal asthma treat-
ment are able to participate on an equal level with their
peers in the Olympic Games and in other top level
international competitions. Fitch even described that
asthmatic athletes even succeeded to win more medals
than other athletes (10).
On the other hand, it is well known that asthmatic
children suffering from EIA will become passive and
participate at a low level in physical activity and play.
Strunk reported that physical fitness was related to self-
perception and psychological functioning in asthmatic
children (11). However, a more recent study showed that
although mild-to-moderate asthma had a moderate im-
pact upon daily life quality in children, it did not seem to
influence psychological functioning of the child or the
family (12). Thus, optimal treatment of EIA becomes as
important in the child with asthma as in the elite athlete
with asthma, and in the common international asthma
treatment guidelines, mastering EIA during childhood is
one of the main aims of treating asthmatic children (13, 14).
EIA and EIB: pathophysiological background
Pathogenic mechanisms of EIA/EIB probably differ in
the athlete compared to children, adolescent, or adult
with asthma (15).
Exercise is a quantifiable and reproducible stressor that
can be modified experimentally and can be considered as
a model of stress (16). It has an effect on the endocrine
activity and the nervous and the immune systems, thereby
activating several complex interacting mechanisms within
the psycho-neuro-immune-endocrine pathways (17).
Classical mechanisms behind EIA and EIB include
the so-called osmolar (or airway drying) and vascular (or
‘thermal’) hypothesis. Both hypotheses are based on the
marked increased ventilation during physical activity,
leading to increased water and heat loss through respira-
tion. Increased water loss increases the osmolality of the
extracellular fluid lining the bronchial mucosa, causing
water to move extracellularly possible through the water
channels, aquaporins, and bronchial epithelial cells to
‘shrink’, with an increase of intracellular ion concentra-
tion (18) and release of inflammatory mediators from
mast cells, eosinophils, neutrophils, and other inflamma-
tory cells including newly formed eicosanoids (19, 20).
The epithelium may serve as a key regulator of the
balance of eicosanoids in the airways by activating the
release of bronchoconstrictive eicosanoids in inflamma-
tory cells in close contact and by alterations that reduce
the synthesis of the protective PGE2 (21).
The ‘Vascular’ or ‘Thermal’ hypothesis involves airway
rewarming after cooling of the airways as the initiating
mechanism. During normal tidal breathing, the nose func-
tions like a rebreathing organ with warming up (up to
378C) and humidifying the inspired air. The respiratory
heat loss increases with increasing exercise intensity due
to the increased ventilation. If the inhaled air is cold,
the respiratory heat loss with the resulting cooling of the
airways is further enhanced (15, 22, 23). The cooling of the
airways results in reflex parasympathetic nerve stimula-
tion causing bronchoconstriction through the vagal nerve
(24). At first, it is notable that a reflex vasoconstriction
of bronchial venules to conserve heat occurs, but when
exercise ceases, the increased ventilation ceases, as does
the cooling stimulus, causing a rebound vasodilatation of
the peribronchial venules. The resulting smooth muscle
constriction due to nerve stimulation and mucosal oedema
due to vasodilatation in susceptible individuals reduces
the size of the bronchial lumen with increased airways
resistance (25). The main factor is now thought to be the
inflammation induced by changes in airway osmolarity,
and both mechanisms (osmolar and thermal) may work
together under conditions of significant heat loss (3).
Also, exercise, with its repeated hyperventilation chal-
lenges, may cause bronchial epithelial damage with
eosinophil and neutrophil influx and increased peptido-
leukotriene concentrations in broncho-alveolar lavage fluid.
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In cultured human bronchial epithelial cells, experimental
exposure to a hyperosmolar medium or the cooling
rewarming process is capable of triggering an inflam-
matory cascade by increasing the expression of various
chemokines and cytokines such as IL-8 and RANTES
(Regulated on Activation, Normal T cell Expressed and
Secreted). This may suggest a possible mechanism for
exercise-induced leukocyte migration into the airways
(26, 27). Athletes of different sports show an increased
number of inflammatory cells in induced sputum, when
measured at rest. Furthermore, pro-inflammatory cytokines
are increased after prolonged, strenuous exercise (28). This
interplay between hyperventilation, hyperosmolarity, and
immune changes seems capable of causing a multi-factorial
bronchial inflammatory response, involving common path-
ways of allergic and asthmatic inflammation.
Finally, the impact of rhinitis on asthma must also be
considered (29). Epidemiological studies indicate that
asthma and rhinitis frequently coexist, even in the absence
of atopy (30). A total of 8090% of asthma patients may
report rhinitis symptoms and 1938% of patients with
allergic rhinitis report symptoms of asthma. Rhinitis is
also very frequently found in athletes (31), with a variable
prevalence depending on the criteria used for diagnosis in
different studies. In a Swiss study, athletes with hay fever
had significantly more frequent exercise-related airway
symptoms, but received inadequate treatment (32).
Why do elite athletes develop asthma?
The prevalence of EIA is higher among elite athletes than
in the general population (33), with a reported prevalence
of up to 22.8% in summer sports and even higher (up to
54.8%) in winter sports. Such variability may depend on a
lack of uniformity in the study methods (e.g. self-reported
questionnaires, anti-doping applications for anti-asthmatic
drug use, spirometry with broncho-reversibility test, etc.).
However, those undertaking endurance sports seem to be
at particular risk. Studies performed in US Olympic
athletes show an increasing trend of the disease with 9.7%
in 1976, 16.7% in 1996 (34), and 21.9% both at Nagano
Winter Games (35) and at the Sydney 2000 Games (36)
being reported. Between 4.2 and 7.7% of Olympic Athletes
had a confirmed diagnosis of asthma with a positive
bronchodilator or a bronchoprovocation test in 2006,
2008, and 2010 Olympic Games (37). In certain groups of
athletes, such as swimmers and skiers, prevalence is even
higher compared to the athlete population in general.
In addition to the type of sport with focus on endurance
training, environmental factors are also of importance.
This includes cold air for cross-country skiers and organic
chlorine products for swimmers (38). The exposure to the
environmental agents is further increased for these athletes
due to their heavily increased ventilation during their daily
repeated training and competitions (9, 39).
In elite endurance athletes, the respiratory epithelial
damage and reduced repair seem to be central in the devel-
opment of inflammation in the athlete’s asthma phenotype
(15, 40). Epithelial damage is the final result of repeated
courses of intensive training sessions and competitions at the
intensity of hyperpnoea necessitated by exercise at an elite
level. This mechanism is partially reversible at the end of
career and is also supported by evidence that transient airway
hyperresponsiveness (AHR) can be associated with periods
of intensive training (4143). In addition, when other
stimuli contribute to this process by causing increased
epithelial damage and inflammation, such as respiratory
virus infections, AHR develops and asthma symptoms
may appear for the first time in previously asymptomatic
athletes, as demonstrated by increased AHR for prolonged
periods of time after respiratory virus infections (39).
The level of exercise load is fundamental, and its rele-
vance was already confirmed by Carlsen et al. in 1989, with
the first findings that AHR correlated with the increase in
exercise load (increase in blood lactate) in both asthmatic
and healthy swimmers (44). A kind of ‘biological gradient’
exists, and can be evaluated by examining exposure time in
a sport or cumulative hours of training and how this
modifies the risk of airway dysfunction (41). Heir and
Larsen (39) reported that airway sensitivity to methacho-
line in cross-country skiers was negatively correlated with
changes in the volume of exercise performed. In addition,
Stensrud et al. (45) observed increased AHR to methacho-
line in elite athletes with increasing age and training volume.
Other authors (46, 47) reported a correlation between
training load and sputum neutrophilia. Furthermore, in
young competitive rowers, the cellularity of induced spu-
tum obtained shortly after ‘all-out’ tests correlates directly
with minute ventilation during the bout (48). Recently, the
finding of an increased number of basophils in the induced
sputum of athletes with and without asthma, but not in
controls, may suggest the role of basophils as new possible
players in the peculiar features of the athlete’s asthma (49).
Data in humans have been confirmed also in exercising
animals, where inflammatory changes in the airways
have been found. In particular, epithelial damage has
been found in exercising mice (50), sledge dogs (51), and
in experimental studies (52), suggesting this to be the
primary lesion in asthma and EIB.
Signs of lung epithelial stress and subsequent inflam-
mation after exercise or bronchoprovocation tests can be
found in some interesting experimental studies. Increased
number of bronchial epithelial cells with apoptosis in
induced sputum after repeated half-marathon races,
in addition to increased serum levels of Clara Cell protein
16 (CC16) and increased supernatant interleukin 8 levels
in induced sputum have been found in endurance runners
(53). Inhaled air humidity and temperature can influence
CC16 urinary levels that have been found increased in
another study, but the levels were reduced when the study
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subjects inhaled warm, humid air during running (54).
Eucapnic voluntary hyperpnoea (EVH) test with dry air
also increased urinary CC16 levels irrespective of the
athletes’ positive or negative bronchoprovocation result
(55). Similar findings have been found in athletes that
underwent a bronchoprovocation test with mannitol (56).
The increased number of columnar epithelial cells in in-
duced sputum of asthmatic patients with EIB, compared
with asthmatic patients without EIB (57), related to degree
of EIB, and associated with the supernatant sputum
levels of cysteinyl leukotrienes, histamine, and increased
expression of MUC5AC (20).
The link between respiratory epithelial damage and
increased airways inflammation is further strengthened
by the role of the ‘inflammasome’ IL-1-Th17 response
in asthma (58). The extracellular water movement across
cell membranes is important in the mechanism of EIA.
Aquaporin (Aqp) is a channel for osmotic aqueous water
transport, expressed in respiratory sub-epithelial glandu-
lar cells and alveolar type 1 cells of the lungs, and mice
lacking the gene for Aqp five show methacholine-induced
bronchiolar hyperresponsiveness compared with normal
mice (59, 60). A relationship between methacholine bron-
chial responsiveness and diminished pilocarpine-induced
sweat secretion, tearing rate, and salivary flow rate in
healthy athletes indicating an autonomic dysfunction
with involvement of the parasympathetic nervous system
has also been demonstrated (59).
The increased parasympathetic activity has also been
demonstrated in endurance runners by Filipe et al. through
pupillometry (61), by Knopfli et al. in two studies repor-
ting higher parasympathetic nervous activity in top cross-
country skiers (62, 63) and indirectly by Deal et al. through
the blocking effect of atropine inhalation on EIB induced
by cold air inhalation, already in 1978 (64).
Which sport for the asthmatic?
One dilemma that physicians caring for athletic adoles-
cents are faced with is what kind of recommendation
should be given to those suffering from asthma. Athletes
who participate in endurance and winter sports as well as
swimming are at higher risk for EIA/EIB. Long-duration
exercise and very low air temperature easily expose these
athletes to the osmolar and vascular changes in the airway,
fundamental in the EIA/EIB pathophysiology. Types of
training and atopy are independent risk factors for EIA/
EIB: combining the two factors in a logistic regression
model, atopic speed, and power athletes have a 25-fold
increased risk of EIA/EIB compared to non-atopic sub-
jects, long-distance runners a 42-fold and swimmers a 92-
fold increased risk (65). In addition, for the asthmatic athlete
it is also important to avoid strenuous exercise during tem-
porarily increased exposure to ‘biological stress’. This can be
increased aeroallergen load, extreme cold air environment,
or strenuous exercise too close to a recent viral respiratory
tract infection. With an early and precise diagnosis,
insightful precaution protecting the airways from extreme
biological stress and an early start of anti-inflammatory
treatment, the progression of bronchial hyperresponsive-
ness and asthma in these athletes may usually be well
controlled. Data from the recent Olympic Games show
that asthmatic athletes have won more medals during
recent Olympic Games than athletes without asthma (10),
demonstrating beyond doubt that the asthmatic athletes
may compete on an equal level with their peers.
Sports with low risk for the development of asthma
and bronchial hyperresponsiveness are the ones in which
the physical effort is of short duration and in which high
ventilatory levels are not reached. Medium-risk sports
are team sports in general, in which the alternation of
aerobic and anaerobic phases, as well as the relatively
brief periods of continuous high-intensity exercise (in any
case usually lower than 58 min) result in a lower risk
of bronchial hyperreactivity. High-risk sports, as already
stated, are endurance and winter sports in general (Table 1).
The swimming issue: is swimming beneficial
or detrimental for asthma?
Swimming has been considered for many years as a safe
and healthy sport activity for children with asthma, due
to the humid air inhaled during swimming thus reducing
the risk of EIA, and suggested to have beneficial effects
on disease severity (66). However, in recent years, several
studies, especially from the group of Bernard, reported a
potential risk of asthma with an increased swimming pool
attendance in children (67). Other studies have demon-
strated the association between the availability of chlori-
nated swimming pools and the prevalence of childhood
asthma (68), independently of climate, altitude, and the
socio-economic status of the country. The findings accord-
ing to the ‘pool chlorine hypothesis’ postulate that the
rise of childhood asthma may partly result from increased
exposure of children to chlorine-based irritants, especially
swimming pool disinfection by-products, such as trich-
loramine. Bernard et al. recently reported that asthma
development during adolescents was clearly associated
with cumulative pool attendance before the age 7 (69).
This hypothesis is further supported by studies on occu-
pational asthma in swimming pool workers and life-
guards (70, 71) and by studies comparing exposures
to non-chlorinated pools (‘coppersilver pools’) (72) vs.
chlorinated pools (73), in which attendance to the latter
exerts a strong adjuvant effect to asthma and allergic
rhinitis. A thorough evaluation of swimming and compet-
ing in chlorinated pools was recently published (74).
Furthermore, very recent studies on mouse models of al-
lergy showed hypochlorite-induced airway hyperreactivity,
without evidence for allergic sensitization (75). All these
studies are partly contradicted by a recent, large birth
cohort study (the Avon Longitudinal Study of Parents
Stefano R. Del Giacco et al.
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and Children birth cohort) (76), in which British children
from birth to the age of 10 did not increase their asthma
risk with swimming pool attendance, and improved their
lung function with a decreased risk of asthma symptoms.
However, although this question is unclear for develop-
ment of asthma throughout childhood, competitive swim-
mers show an increase in asthma prevalence, with a mixed
eosinophilicneutrophilic airways inflammation (77, 78),
epithelial damage (46), and very frequent bronchial hyper-
responsiveness (79). Further, increased levels of leuko-
triene B4 have been reported in elite swimmers (77),
supporting the hypothesis that repeated hyperventilation
challenges (80) together with exposure to chlorine deriva-
tives can contribute to a peculiar inflammation mecha-
nism that may support the theory of a phenotype of its
own for the ‘competitive swimmers’ asthma’, a syndrome
that may be potentially reversible when the athlete quits
the competitive activity (65, 81).
Environmental issues
Various environmental factors may influence performance
in different types of sports. Due to the almost daily
repeated periods of high minute ventilation during the
intense physical activity of training and competitions,
typical for top athletes, they will have a higher exposure
to possible pollutants and allergens in the environmental
air. Different environmental factors may be important for
different types of sports. For cold weather types of sports
like cross-country skiing and biathlon, cold air may be
the harmful environmental factor (15). For other types of
sports, other environmental factors or pollutants may be
important. For water sports taking place in swimming
pools, organic chlorine products originating from chlor-
ine used in the disinfection of the water in the pools are
probably harmful (82), and, as already stated, bronchial
hyperresponsiveness is frequently found in competitive
swimmers (79) as well as airways inflammation (46, 77, 78).
High levels of CO2, NO2, and ultrafine particles are often
present in indoor ice rinks where propane- or gasoline-
powered ice resurfacers and edgers are used (83, 84).
Several studies demonstrated high prevalence of respi-
ratory symptoms in ice-hockey players (85, 86), figure
skaters (87), and speed skaters (88). Electric resurfacers,
increased ventilation, and emission control systems have
been recommended to reduce the exposure (89).
Outdoor sports may expose the athlete to environ-
mental pollutants, and furthermore pollen and moulds
may influence performances and the presence of EIB in
allergic athletes (90). Pollution from traffic may influence
air quality in athletic fields (91).
Diagnosis: current guidelines
EIA should be suspected when cough, wheezing, and
phlegm occur together with expiratory dyspnoea and
audible rhonchi and sibilating rhonchi on lung auscul-
tation after intense exercise of at least 5 min duration.
Table 1. Examples of sports and their potential risk of EIA/EIB
Low-risk sports Medium-risk sports High-risk sports
All sports in which the athlete performs
aB58 min effort
Team sports in general, in which the continuous
effort rarely lasts more than 58 min
All sports in which the athlete performs a
58 min effort and/or in a dry/cold air
environment
Track and field:
 Sprint (100, 200, and 400 m)
 Middle distance (800 and 1,500 m)
 Hurdles (100, 110, and 400 m)
 Jumps
 Throws
 Decathlon
 Heptathlon
Tennis
Fencing
Gymnastics
Downhill skiing
Boxing
Golf
Body building
Weightlifting
Martial arts
Soccer
Rugby
American football
Basketball
Volleyball
Handball
Baseball
Cricket
Field hockey
Track and field:
 Long distance (5,000 and 10,000 m)
 3,000 m steeplechase
 Pentathlon (mixed)
 Walks (20 and 50 km)
 Marathon
 High-altitude sports
Cycling
Cross-country skiing
Ice hockey
Ice skating
Biathlon
Swimming, water polo
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Specific validated questionnaires can help to screen allergic
athletes (92). Differential diagnoses must be considered
(Table 2), bearing in mind that intense physical exercise
may produce increased amounts of respiratory secretions
that may mimic asthmatic symptoms (93). Thus, it is im-
portant to confirm the clinical suspicion by objective
measurements in order to provide the optimal treatment
for the athlete with respiratory problems.
Objective tests were necessary to obtain approval from
the World Anti-Doping Association (WADA) or Inter-
national Olympic Committee for the use of inhaled
corticosteroids (ICSs) and inhaled b2-agonists in inter-
national competitive sports, but from 1st of January 2012
ICSs and the inhaled b2-agonists salbutamol, salmeterol
and formoterol have been taken off the list of prohibited
drugs and now do not have any restrictions for use in
sports.
It has been claimed that a field exercise test is most
likely to reproduce symptoms of the real-life exercise (94),
but this has not been confirmed by other studies (45, 95).
Furthermore, the field exercise test may be inconvenient
both for logistical and standardization issues.
A standardized exercise test or other tests for bronchial
hyperresponsiveness performed in a laboratory can be
performed in a standardized way, including both envir-
onmental issues and exercise load by objective measures.
Exercise tests can be performed by means of a motorized
treadmill or a cycle ergometer, in a temperature- and
humidity-controlled environment: the absolute water con-
tent should be below 10 mg H2O L1; otherwise, the test
should be postponed until conditions become suitable
(96). A very high workload is necessary to induce EIB
which athletes can sometimes find difficult to reach in a
lab environment. A key requirement is the ventilation
reached and sustained with a target workload of 6080%
of the predicted Maximum Voluntary Ventilation that
must be sustained for the last 4 min of an 8-min test (97).
Heart rate recorded electronically or by electrocardio-
gram is also frequently used as a measure of exercise
load. In a 6-min treadmill test, the speed of the treadmill
is increased over the first 2 min to reach a level of 9095%
of maximum heart rate, which is sustained for the 4 min.
The objective tests of bronchial responsiveness are divi-
ded into ‘direct tests’ (methacholine, histamine) and ‘indirect
tests’ (exercise, mannitol, adenosine 5?-monophosphate
[AMP], non-isotonic aerosols, and hyperpnoea [EVH]).
The methacholine (MCH) test is widely used. MCH acts
as an analogue of acetylcholine, directly stimulating the
cholinergic receptors in the airways’ smooth muscle. It has
a high sensitivity but a low specificity for active asthma
(45, 98), and a low sensitivity to identify EIB (99).
Mannitol is an osmotic agent that mimics the ‘osmolar’
mechanism of EIA/EIB, compares to the exercise test,
and shows a similar sensitivity and specificity with MCH
for the diagnosis of EIA/EIB (99101).
The EVH test requires the subject to ventilate dry air
containing 5% CO2 for 6 min through a low-resistance
circuit at a rate higher than that usually achieved on maxi-
mum exercise (102). Test is positive when a ]10% sus-
tained reduction in FEV1 is achieved. Very recent data,
however, showed poor clinical reproducibility for the diag-
nosis of EIB in a cohort of recreational athletes (103),
supporting the recommendations of a recent review in
which bronchial provocation using both a direct and an
indirect test is useful in some patients to confirm or
exclude a diagnosis of asthma with certainty (104). A very
basic exercise test that may help family doctors and
paediatricians to suspect a primary diagnosis of EIA/EIB
and refer the patient to a specialised centre is the ‘free-
running asthma screening test’ (FRAST). FRAST mea-
sures peak expiratory flow rate before and at 1, 5, and
10 min after maximum voluntary running for at least
5 min, and it represents an acceptable, feasible, and cost-
effective screening test (105), even if not in line with the
most recent guidelines. In a recent study on elite swim-
mers it was suggested that parameters other than the
direct drop in FEV compared to baseline should also be
considered in the evaluation. Some subjects improve FEV
during exercise with a subsequent drop after exercise pro-
viding a variability in FEV exceeding 15% (variability).
Some subjects, previously without confirmed reversibility
may respond to b2 with marked improved FEV compared
to maximum drop after exercise (reversibility). Thus,
when both direct EIB, significant variability or reversibility
were considered, a closer association between symptoms
and disease activity was found (106).
Treatment: current guidelines
The treatment of EIA and of asthma in athletes should
follow the same international guidelines as for the indi-
vidual with general asthmatic symptoms. In all interna-
tional guidelines for treating asthma in children and
adults, a major aim of the treatment is to master EIA,
as physical activity is seen as very important for the
development and growth of children and for the self-
perception. Fitness was found to correlate with psy-
chological functioning in children with asthma (11).
Considering that inflammation is the final result of
the osmolar and vascular modifications described, anti-
inflammatory treatment through inhaled steroids is
often effective and sufficient to achieve a good EIA/EIB
control (93). It should be noted that ICSs are the only
anti-inflammatory drugs that improve respiratory epithe-
lial healing (107). ICSs reduce the damage induced by
repeated training and competitions, as we have seen for
the phenotype of the ‘athlete’s asthma’, enabling the
athletes to master their sports and improving the long-
term prognosis (10). However, a study in cross-country
skiers showed no benefit from budesonide 800 mg/day
during 3 months of treatment (108).
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Table 2. Exercise-induced asthma: differential diagnosis
Diagnosis Relevant for: Clinical presentation Verification of diagnosis
EIA Symptoms occur shortly after (sometimes during) physical exercise.
The dyspnoea is of expiratory type. By auscultation: rhonchi and sibilating
rhonchi. Respiratory retractions. Gradual improvement either spontaneously
or after inhaled bronchodilator.
Exercise test with sub-maximal exercise load
(95% load). Spirometry before and after
exercise.
Exercise-induced
laryngeal obstruction
(EILO)
Asthmatics and individuals
active in sports
Symptoms occur during maximum exertion. Symptoms disappear when
exercise is stopped unless the patient continues to hyperventilate. The
dyspnoea is of inspiratory type. There are audible inspiratory sounds from the
laryngeal area and no signs of bronchial obstruction. No effect of pre-
treatment with inhaled bronchodilator.
Exercise test with maximal exercise load,
68 min duration.
Direct laryngoscopy during exercise test.
Exercise-induced
hyperventilation
Individuals active in sports,
general population
Hyperventilation with respiratory dyspnoea and decreased end-tidal CO2. Case history, observation during dyspnoea.
Exercise-induced arterial
hypoxemia (EIAH)
Individuals active in sports Occurs in well-trained athletes with high maximum oxygen uptake. Thought to
be due to diffusion limitations and ventilationperfusion inequality. Incomplete
diffusion in the healthy lung may be due to a rapid red blood cell transit time
through the pulmonary capillaries.
Exercise test, sub-maximal to maximal level.
Swimming-induced
pulmonary oedema
(SIPE)
Individuals active in sports May occur after heavy swimming exercises with symptoms of haemoptysis,
cough, and respiratory distress. Reduced diffusion capacity (TLCO) for up to
weeks afterwards.
Case history, clinical examination, and lung
function measurements during an active
episode.
Other chronic lung
diseases
Individuals with chronic lung
disease
Reduced baseline lung function may reduce physical performance due to
limitations in airflow and lung volumes.
Exercise test with measurement of tidal flow
volume loops during exercise.
Other general disease Individuals with chronic
illnesses  cardiovascular
disorders
Chronic heart diseases and others general disorders. General diagnostic workout.
Poor physical fitness
including obesity
General population Related to expectations. High heart rate after low-grade exercise load. Exercise test: assessment of physical fitness
by determination of V’O2max or maximal
exercise load.
Modified with permission from (93).
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Inhaled short-acting b2-agonists are frequently needed
and strongly suggested as pre-treatment before competi-
tion. If insufficient, long-acting b2-agonists (LABAs) and
leukotriene antagonists may be added. Ipratropium bro-
mide can be tried in addition to other treatments and
after individual assessment (see flow chart in Fig. 1)
(109). Based on the finding of increased parasympathetic
tone in endurance athletes (110), the contribution of
increased parasympathetic activity in the development of
asthma in athletes would suggest a speculation for the
role of inhaled ipratropium bromide or tiotropium in the
treatment of asthma in athletes (15).
It is important to underline some concerns raised
about tolerance of regular use of b2-agonists in EIA/EIB.
First, there is a significant minority (1520%) of asth-
matics whose EIA is not prevented by b2-agonists, even
when ICSs are used concomitantly; second, b2-agonists
long-term regular use induces tolerance, with a decline in
duration of the protective effect with their daily use, and
lacks of sufficient safety data (111, 112). In addition, a
recent report raised attention on a potential loss of bron-
choprotection for athletes using LABAs, independent
from the Arg16Gly polymorphisms that may affect the
efficacy of these medications (113). Non-pharmacological
measures are also of importance: nasal breathing and
pre-exercise warm-ups (1530 sec exertions alternate
with 6090 sec rest) followed by a warm-down segment
are suggested (114), together with anti-cold masks for
cold environments.
Anti-doping: current regulations
For many years, the WADA issued strict regulations for
the use of asthma drugs in sports. Initially, one feared that
these drugs might improve performance, but after several
studies on maximum performance in healthy subjects
after inhaled b2-agonists, both short- and long-acting,
it is generally accepted that inhaled steroids and inhaled
b2-agonists do not improve performance. In a recent
study combining three b2-agonists (salbutamol, formo-
terol, and salmeterol) all in WADA permitted doses, small
but significant improvements could be seen in isometric
quadriceps contraction and swim ergometric sprint per-
formance. However, swim performance in an exhaustive
race of 110 m did not improve (115). Since 1 January 2012,
all ICSs have not been on the prohibited list, as well as the
inhaled b2-agonists salbutamol, salmeterol, and formo-
terol. At present, there are no restrictions for the use of
inhaled steroids; inhaled ipratropium bromide; leuko-
triene antagonists; and the inhaled b2-agonists salbuta-
mol, salmeterol, and formoterol. Still, inhaled terbutaline
is restricted in competitive sports, and objective measure-
ments of AHR, EIB, or bronchodilator reversibility must
be documented for approval of its use. Oral corticosteroids
and oral or intravenous b2-agonists are prohibited.
Fig. 1. Simplified flow-chart for EIA treatment.
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The list of prohibited drugs is usually updated every
year and can be found on the WADA website (www.wada-
ama.org).
Exercise to improve exercise-induced
symptoms: from animal models to field
At present, it is clear that strenuous exercise increases the
risk for asthma development assuming a doseresponse
relationship between physical activity and EIA/EIB risk
(see Fig. 2), with a ‘U’-shaped curve showing that mode-
rate exercise training carries a lower risk of asthma in
comparison to high-intensity exercise training especially
endurance training and interval training. These observa-
tions are confirmed by a growing number of studies on
the murine model of allergic asthma: low-to-moderate in-
tensity aerobic exercise decreases eosinophilic and lym-
phocytic inflammation in mice exercising for 4 weeks,
5 days a week, at 50% exercise capacity (116). Aerobic
exercise seems to reduce airway remodelling, with reduced
airway smooth muscle hypertrophy and hyperplasia (116),
a reduction in leukocyte infiltration, pro-inflammatory
cytokine production, adhesion molecules expression (117),
and enhanced regulatory T cell (Treg) responses (118).
Aerobic exercise also shows an anti-inflammatory effect in
mice exposed to air pollution (119). Furthermore, a single
session of moderate aerobic exercise can decrease airway
inflammation (but not bronchial responsiveness) in mice,
with a down-regulation of inflammatory mediators’ genes
expression and Th-2 derived cytokines production (120).
Similar findings are also being demonstrated in humans,
where a reduction in neutrophils count in patients with
chronic inflammatory conditions has been observed (121).
Another recent study on humans (122) showed that asth-
matic patients subjected to aerobic exercise training have
a reduction in the number of eosinophils in induced
sputum and lower levels of FeNO. In addition, Moreira
et al. also demonstrated, in children with persistent allergic
asthma, that a physical training program did not increase
airways inflammation but decreased their total and
allergen-specific IgE levels (123). Finally, preliminary
data show that regular exercise reduces IL-2 production,
meaning that lymphocytes are probably less responsive
to exogenous stimuli, and IL-4 producing lymphocytes
are also reduced, suggesting a better clinical condition for
allergic people that exercise regularly (124).
Therefore, it is apparent that aerobic, moderate-intensity
exercise training (e.g. running or cycling) can be beneficial
for allergic inflammation: these data open a new door
on the possibility for ‘exercise therapy’ for asthmatics, in
which exercise, in general a potential trigger for EIA/EIB,
is instead a comprehensive part of the prevention and
therapy strategies for asthmatics. However, on the other
hand it has been shown that physical training programs
in asthmatics improve cardiovascular fitness, but do not
improve baseline lung function or bronchial hyperrespon-
siveness (125).
Conclusion
EIA/EIB are highly common, and their prevalence is
markedly increased in competitive athletes, especially
within endurance sports. The role of swimming as an
‘asthmogenic’ or ‘non-asthmogenic’ sport in childhood
is still debated, but for competitive swimmers sufficient
evidence exists for the increased prevalence of asthma
and bronchial hyperresponsiveness in young competitive
swimmers. There are now convincing data implicating
immune-mediated airway inflammation and epithelial
damage in EIA/EIB pathogenesis together with an in-
creased parasympathetic activity, and this improved
understanding of the underlying mechanisms may lead
to new treatments in terms of new drugs and different stra-
tegies focused on different therapeutic approaches based
on different phenotypes and endotypes (126). Further-
more, murine models and preliminary studies on humans
have demonstrated that exercise, despite being the cause of
EIA/EIB, can also be a new tool for its treatment, and
exercise prescriptions should be included in the treatment
guidelines for EIA/EIB.
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